SCHEMBL959623

SCHEMBL959623

CC(O)(CCNc1nc(-c2ccccc2)cs1)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
RAB9A P51151 7/20 0.59
NPC1 O15118 6/20 0.59
ALDH1A1 P00352 5/20 0.59
STAT1 P42224 1/20 0.59
GAA P10253 5/20 0.51
KDM4E B2RXH2 2/20 0.51
HTT P42858 1/20 0.51
MEN1 O00255 7/20 0.48
KMT2A Q03164 7/20 0.48
POLB P06746 1/20 0.48
LMNA P02545 3/20 0.48
GFER P55789 2/20 0.48
ALOX12 P18054 1/20 0.48
ROCK2 O75116 1/20 0.47
ROCK1 Q13464 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
ELOVL1 Q9BW60 1/20 0.45
ALOX5 P09917 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1819107 0.80 NPC1 (0.62) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL1747328 0.78 RAB9A (0.81) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL10352100 0.78 MAPT (0.67) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL29470100 0.76 RAB9A (0.61) MAPTRAB9ANPC1ALDH1A1STAT1
Hydrochloric Acid SCHEMBL10352099 0.76 MAPT (0.65) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL6695940 0.75 MAPT (0.59) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL10475630 0.75 MAPT (0.91) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL1747419 0.74 MEN1 (0.71) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL1746613 0.74 MAPT (0.66) MAPTRAB9ANPC1ALDH1A1STAT1
SCHEMBL1724171 0.74 MAPT (1.00) MAPTRAB9ANPC1ALDH1A1STAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183228-B1 CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 VITAE PHARMACEUTICALS INC (US) 2014-08-20 EP disclosed
US-8575156-B2 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2013-11-05 US disclosed
US-8575156-B2 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2013-11-05 US disclosed
US-8575156-B2 Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 VITAE PHARMACEUTICALS, INC. (US) 2013-11-05 US disclosed
US-20110015157-A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 Vitae Pharmaceuticals ,Inc. 2011-01-20 US disclosed
EP-2183228-A1 CYCLIC INHIBITORS OF 11ß -HYDROXYSTERIOD DEHYDROGENASE 1 Vitae Pharmaceuticals, Inc. (US) 2010-05-12 EP disclosed
WO-2009017664-A1 CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. (US) 2009-02-05 WO disclosed
WO-2009017664-A1 CYCLIC INHIBITORS OF 11β-HYDROXYSTERIOD DEHYDROGENASE 1 VITAE PHARMACEUTICALS, INC. (US) 2009-02-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110015157-A1 CYCLIC INHIBITORS OF 11BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD11B2, HSD3B1 MAPT 3693/4885RAB9A 4131/4885NPC1 504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.